Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00328861 | Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer | completed | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 5, 2012 | clinicaltrials |
| NCT00059475 | Peptide Vaccination for Patients at High Risk for Recurrent Melanoma | completed | Phase 2 | 138 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00273910 | Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma | completed | Phase 2 | 104 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2012 | clinicaltrials |
| NCT00314106 | Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00862914 | Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi | completed | — | 30 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01444560 | miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi | completed | — | 21 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00785369 | In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis | completed | N/A | 441 | Lucid, Inc.INDUSTRY | 1 | Oct 3, 2012 | clinicaltrials |
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | completed | Phase 1 / Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00798629 | Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured | completed | Phase 1 | 13 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT00003828 | S9804: Vinorelbine in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 24 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00104988 | S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 64 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00062933 | A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2012 | clinicaltrials |
| NCT01294735 | Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) | completed | Phase 1 | 19 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00506311 | Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients | completed | N/A | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00527761 | Taxotere/Temodar/Cisplatin Study in Melanoma Patients | completed | Phase 1 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00014625 | E7070 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 24, 2012 | clinicaltrials |
| NCT00003989 | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00023647 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 26 | Mannkind CorporationINDUSTRY | 1 | Jul 10, 2012 | clinicaltrials |
| NCT00002669 | Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 90 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00094107 | Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00077532 | Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 179 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 22, 2012 | clinicaltrials |
| NCT00085462 | Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 61 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 22, 2012 | clinicaltrials |
| NCT01161888 | Effect of Topical Imiquimod on Lentigo Maligna(LIMIT-1) | completed | Phase 4 | 30 | Jerry MarsdenOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00080353 | Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00295958 | LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00846833 | Haploidentical NK Cell Infusion in Malignant Melanoma | completed | Phase 1 / Phase 2 | 12 | Seoul National University HospitalOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00254579 | Study of CP-675,206 in Refractory Melanoma | completed | Phase 2 | 251 | AstraZenecaINDUSTRY | 9 | Jun 7, 2012 | clinicaltrials |
| NCT00281541 | A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma | completed | Phase 2 | 29 | Astellas Pharma IncINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00086489 | CP-675,206 In Patients With Advanced Melanoma | completed | Phase 2 | 118 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00431275 | Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody | completed | Phase 1 | 85 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00412425 | Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | completed | Phase 1 / Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00483301 | A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma | completed | Phase 2 | 34 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 3, 2012 | clinicaltrials |
| NCT00616564 | Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma | completed | Phase 2 | 36 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 3, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00750399 | Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma | completed | Phase 1 | 10 | The New York Eye Cancer CenterOTHER | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00035165 | EPO906 Therapy in Patients With Advanced Melanoma | completed | Phase 2 | 51 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01048554 | Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System(MEL0107) | completed | Phase 2 | 34 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01052142 | Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma | completed | Phase 1 | 12 | Lipotek Pty LtdINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00828126 | PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma | completed | — | 38 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00438984 | Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 11 | Fred Hutchinson Cancer Research Center/University of Washington Cancer ConsortiumOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00091104 | Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 136 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00316901 | Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial | completed | Phase 2 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00111696 | Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma | completed | Phase 1 | 18 | MedImmune LLCINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00542893 | A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine | completed | Phase 1 | — | Genta IncorporatedINDUSTRY | 0 | Mar 13, 2012 | clinicaltrials |
| NCT00434057 | Evaluation of Pigmented Skin Lesions With MelaFind(R) System | completed | Phase 3 | 1,383 | MELA Sciences, Inc.INDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT01011153 | Survey Study - Sensitivity Comparison Between MelaFind and Physician Group | completed | — | 241 | MELA Sciences, Inc.INDUSTRY | 0 | Feb 14, 2012 | clinicaltrials |
| NCT00002860 | SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 77 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 13, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Nov 5, 2012source: clinicaltrials